Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enochian Biosciences Inc (NQ: ENOB )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Enochian Biosciences Inc

< Previous 1 2 3 Next >
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences’ CEO Letter to Shareholders
Turning the Page; A Promising Future 
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
From Enochian BioSciences, Inc.
Via GlobeNewswire
NASDAQ:ENOB Long-Term Investor Notice: Investigation over Potential Wrongdoing at Enochian Biosciences, Inc.
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Enochian Biosciences, Inc. are under investigation over possible breaches of fiduciary duties. 
Via SBWire
Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K
From Enochian BioSciences, Inc.
Via GlobeNewswire
Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform
Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer 
From Enochian BioSciences, Inc.
Via GlobeNewswire
ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
From The Law Offices of Frank R. Cruz
Via Business Wire
ENOB FINAL DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ENOB FINAL DEADLINE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.